Breast cancer (BC) is the most prevalent cancer globally among women.(1) Treatment and prognosis hinge substantially on the cancer subtype, which is defined by the presence of the surface proteins estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.